AI assistant
Sending…
GlaxoSmithKline PLC — Director's Dealing 2017
Mar 6, 2017
5262_rns_2017-03-06_ffcbe982-6c0c-4237-ae0c-c4967894fa65.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 6626Y
GlaxoSmithKline PLC
06 March 2017
GlaxoSmithKline plc (the 'Company')
Transaction notification
| 1. | Details of PDMR/person closely associated with them ('PCA') | ||||
| a) | Name | Mr S A Hussain | |||
| b) | Position/status | President, Global Pharmaceuticals | |||
| c) | Initial notification/ amendment |
Initial Notification | |||
| 2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | GlaxoSmithKline plc | |||
| b) | LEI | 5493000HZTVUYLO1D793 | |||
| 3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
| a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882 |
|||
| b) | Nature of the transaction | The sale of 98,581.776 Ordinary Shares on 6 March 2017 at a price of £16.8006. | |||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
| £16.8006 | 98,581.776 | ||||
| d) | Aggregated information | n/a (single transaction) | |||
| Aggregated volume Price | |||||
| e) | Date of the transaction | 2017-03-06 | |||
| f) | Place of the transaction | London Stock Exchange (XLON) |
| 1. | Details of PDMR/person closely associated with them ('PCA') | ||||
| a) | Name | Mrs S G Hussain | |||
| b) | Position/status | PCA of Mr S A Hussain (President, Global Pharmaceuticals) | |||
| c) | Initial notification/ amendment |
Initial Notification | |||
| 2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | GlaxoSmithKline plc | |||
| b) | LEI | 5493000HZTVUYLO1D793 | |||
| 3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
| a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882 |
|||
| b) | Nature of the transaction | The sale of 131,418 Ordinary Shares on 6 March 2017 at a price of £16.835. | |||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
| £16.835 | 131,418 | ||||
| d) | Aggregated information | n/a (single transaction) | |||
| Aggregated volume Price | |||||
| e) | Date of the transaction | 2017-03-06 | |||
| f) | Place of the transaction | London Stock Exchange (XLON) |
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHQQLFBDXFZBBV
More from GlaxoSmithKline PLC
Report Publication Announcement
2026
May 22
Regulatory Filings
2026
May 22
Director's Dealing
2026
May 20
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 20
Director's Dealing
2026
May 19
Regulatory Filings
2026
May 19
Transaction in Own Shares
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18